FDA Approved: ROFLUMILAST — Original Application (Jubilant Cadista Pharmaceuticals Inc.)

View source ↗

Summary

FDA approved Jubilant Cadista's original application for roflumilast, a PDE-4 inhibitor, to reduce the risk of COPD exacerbations in adults with severe COPD ass…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bronchitis
• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• Roflumilast (roflumilast)

Snippet

ORIG AP for ROFLUMILAST (ROFLUMILAST)